SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies. - Bui QT; Basavaraja R; Dhamdhere MR; Holczbauer Å; Paruzzo L; Guruprasad P; Scaglione M; Tang Y; Sun Y; Beiting DP; Nash EK; Fazelinia H; et al. (BioRxiv : the preprint server for biology, 2026)